High-resolution tracking of cell division demonstrates differential effects of TH1 and TH2 cytokines on SCF-dependent human mast cell production in vitro: Correlation with apoptosis and Kit expression

Blood

Volumn 105, Issue 2, 2005, Pages 592-599

  Kulka, Marianna ^a   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; HISTAMINE; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DIVISION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL;

EID: 11244304178     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2838     Document Type: Article

References (27)

1. Lorentz A, Bischoff SC. Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol Rev. 2001;179:57-60.
2. Oskeritzian CA, Wang Z, Kochan JP, et al. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J Immunol. 1999; 163:5105-5115.
3. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med. 1999;19;190:267-280.
4. Toru H, Eguchi M, Matsumoto R, Yanagida M, Yata J, Nakahata T. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood. 1998;91:187-195.
5. Goselink HM, Williams DE, Fibbe WE, et al. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells. Blood. 1992; 80:750-757.
6. Yanagida M, Fukamachi H, Ohgami K, et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood. 1995;86:3705-3714.
7. Kirshenbaum AS, Akin C, Wu Y, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia: activation following aggregation of FcεRI or FcγRI. Leuk Res. 2003;27:677-682.
8. Kirshenbaum AS, Worobec AS, Davis TA, Goff JP, Semere T, Metcalfe DD. Inhibition of human mast cell growth and differentiation by interferon gamma-1b. Exp Hematol. 1998;26:245-251.
9. Bischoff SC, Selige G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA. 1999;96:8080-8085.
10. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol. 1991;146:1410-1415.
11. Nordon RE, Ginsberg SS, Eaves CJ. High-resolution cell division tracking demonstrates the FLt3-ligand dependence of human marrow CD34+CD38- cell production in vitro. Br J Haematol. 1997;98:528-539.
12. Woolhiser MR, Brockow K, Metcalfe DD. Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a. Clin Immunol. 2004;110:172-180.
13. Lavens SE, Proud D, Warner JA. A sensitive colorimetric assay for the release of tryptase from human lung mast cells in vitro. J Immunol Methods. 1993;166:93-102.
14. Tachimoto H, Ebisawa M, Hasegawa T, et al. Reciprocal regulation of cultured human mast cell cytokine production by IL-4 and IFN-gamma. J Allergy Clin Immunol. 2000;106:141-149.
15. Toru H, Kinashi T, Ra C, Nonoyama S, Yata J, Nakahata T. Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood. 1997;89: 3296-3302.
16. Woolhiser MR, Okayama Y, Gilfillan AM, Metcalfe DD. IgG-dependent activation of human mast cells following up-regulation of FcγRI by IFN-γ. Eur J Immunol. 2001;31:3298-3307.
17. Okayama Y, Hagaman DD, Woolhiser M, Metcalfe DD. Further characterization of FcγRII and FcγRIII expression by cultured human mast cells, Int Arch Allergy Immunol. 2001;124:155-157.
18. Okayama Y, Semper A, Holgate ST, Church MK. Multiple cytokine mRNA expression in human mast cells stimulated via Fc epsilon RI. Int Arch Allergy Immunol. 1995;107:158-159.
19. Okayama Y, Petit-Frere C, Kassel O, et al. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol. 1995;155: 1796-1808.
20. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A. 1999;96:8080-8085.
21. Boyce JA. The role of mast cells in asthma. Prostaglandins Leukot Essent Fatty Acids. 2003;69:195-205.
22. Williams CM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol. 2000; 105:847-859.
23. Hagaman DD, Okayama Y, D'Ambrosio C, Prussin C, Gilfillan AM, Metcalfe DD. Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge. Am J Respir Cell Mol Biol. 2001;25:685-69l.
24. Grunewald SM, Werthmann A, Schnarr B, et al. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J Immunol. 1998;160:4004-4009.
25. Borish LC, Nelson HS, Corren J, et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol. 2001;107: 963-970.
26. Li XM, Chopra RK, Chou TY, Schofield BH, Wills-Karp M, Huang SK. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol. 1996;157:3216-3219.
27. Prummer O, Fiehn C, Gallati H. Anti-interferon-gamma antibodies in a patient undergoing interferon-gamma treatment for systemic mastocytosis. J Interferon Cytokine Res. 1996;16: 519-522.